The Comprehensive Organic Acids Quantitative Urine Test analyzes a broad spectrum of metabolites—organic acids—in urine to assess metabolic pathway function. By quantifying markers of detoxification, mitochondrial energy, and microbial metabolism, this test can help detect inborn errors, mitochondrial dysfunction, or dysbiosis.

The Amino Acid Analysis Plasma Test measures levels of essential and non-essential amino acids in blood to evaluate metabolic health, nutritional status, and inherited disorders. Abnormal results may indicate malnutrition, liver disease, kidney dysfunction, or inborn errors of metabolism. Doctors order this test for patients with developmental delays, unexplained weakness, or metabolic concerns. Results help guide diagnosis, treatment, and nutritional management.

The Lactic Acid Plasma Test measures lactic acid levels in the blood to help evaluate oxygen delivery, metabolic function, and tissue health. Elevated levels may signal hypoxia, sepsis, shock, heart failure, or severe infection, while mild increases can occur with intense exercise. Doctors use this test to assess critically ill patients, guide urgent treatment, and monitor metabolic or circulatory disorders for timely medical intervention.

The Protein & Amino Acid Utilization Panel — Comprehensive provides an in-depth evaluation of how protein and amino acids are absorbed and used at the metabolic level. By combining plasma amino acid analysis, prealbumin, IGF-1, functional markers, vitamin B12 and folate, creatinine, and a Comprehensive Metabolic Panel, this panel delivers a clear view of protein utilization, nutritional status, and metabolic efficiency.

The Oxalic Acid, 24-Hour Urine with Creatinine test is a diagnostic tool used to measure the levels of oxalic acid (oxalate) and creatinine in a patient's urine over a 24-hour period. Oxalic acid is a naturally occurring substance in the body, derived from dietary sources and metabolic processes. It plays a significant role in kidney function and metabolic health. Elevated levels of oxalate in the urine can contribute to kidney stone formation and may indicate underlying metabolic disorders. This test is particularly useful in assessing the risk of calcium oxalate kidney stones, evaluating kidney function, and diagnosing certain metabolic disorders. The inclusion of creatinine measurement allows for a more accurate interpretation of oxalate excretion by normalizing results relative to kidney function.

Comprehensive organ function and kidney health panel including a full metabolic panel and complete urinalysis. Evaluates kidney filtration (creatinine, eGFR), liver enzymes, electrolytes, glucose, protein balance, and detailed urine analysis to assess renal function, metabolic health, and urinary tract status in one integrated evaluation.

The Clostridium difficile Toxin/GDH Test with Reflex to Qualitative PCR screens for C. difficile toxins and GDH antigen, organisms often linked to antibiotic-associated diarrhea. Reflex PCR helps confirm diagnosis in unclear cases. This test aids in evaluating gastrointestinal function, infection risk, toxin activity, and systemic health effects of C. difficile–related disease.

The Lactate Dehydrogenase (LDH) Isoenzyme Panel measures total LDH and separates it into isoenzymes (LDH-1 to LDH-5) to identify tissue damage. LDH-1 is linked to heart, LDH-2 to blood, LDH-3 to lungs, LDH-4 to kidneys, and LDH-5 to liver and muscle. Elevated levels may indicate heart attack, liver disease, anemia, or cancer. Doctors order this test to pinpoint tissue injury, monitor disease progression, and guide treatment strategies.

Comprehensive panel evaluating cardiac strain, myocardial injury, kidney function, metabolic balance, and glycemic control. Measures NT-proBNP, high-sensitivity Troponin T, A1c, CMP, CBC, and urinary albumin to assess the systemic impact of vascular aging and cardiometabolic stress. Designed for structured end-organ surveillance and proactive cardiovascular health monitoring.

The Comprehensive Fatty Acid Profile (C8–C26) analyzes 40+ fatty acids in serum—including medium, long, and very long chain species—to evaluate mitochondrial β-oxidation, peroxisomal disorders, essential fatty acid deficiency, or nutritional status. Abnormal patterns (e.g. elevated VLCFAs, altered w3/w6 ratios) help detect metabolic or peroxisomal defects and guide dietary or therapeutic interventions.